MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Polaryx Therapeutics, Inc. (PLYX)
Polaryx Therapeutics, Inc. (PLYX)
source: myfinsight.com
Net loss and
comprehensive loss
-$2,544K
Operating loss
-$1,958K
Other expense direct
listing offering costs
$586K
Total operating
expenses
$1,958K
General and
administrative expenses
$1,279K
Research and development
expenses
$679K
Back